Omega-3 fatty acids to augment cancer therapy

Journal of Nutrition

Volumn 132, Issue 11 SUPPL., 2002, Pages

  Hardman, W Elaine ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Cancer; Cancer survival; Nutrition; Omega 3 fatty acids

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMEGA 3 FATTY ACID; PROTEIN BCL 2; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CACHEXIA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; FAT INTAKE; GENE EXPRESSION; LONGEVITY; MOUSE; NONHUMAN; QUALITY OF LIFE; TUMOR XENOGRAFT;

ANIMALIA;

EID: 0036846075     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.11.3508s     Document Type: Conference Paper

References (72)

1. Hardman, W. E., Moyer, M. P. & Cameron, I. L. (2000) Dietary fish oil sensitizes A549 lung xenografts to doxorubicin chemotherapy. Cancer Lett. 151: 145-151.
2. Hardman, W. E., Moyer, M. P. & Cameron, I. L. (1999) Fish oil supplementation enhanced CPT-11 (Irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side effects. Br. J. Cancer 81: 440-448.
3. Hardman, W. E., Moyer, M. P. & Cameron, I. L. (2002) Small amounts of a concentrated omega-3 fatty acid product, INCELL AAFA, in the diet reduces the side-effects of the cancer chemotherapy drug, CPT-11 (irinotecan). Br. J. Cancer 86: 983-988.
4. Hardman, W. E., Avula, C. P. R., Fernandes, G. & Cameron, I. L. (2001) Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 human breast cancer xenografts. Clin. Cancer Res. 7: 2041-2049.
5. Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J. & Fearon, K. C. H. (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br. J. Cancer 81: 80-86.
6. Beck, S. A., Smith, K. L. & Tisdale, M. J. (1991) Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res. 51: 6089-6093.
7. Li, D., Ng, A., Mann, N. J. & Sinclair, A. (1998) Contribution of meat fat to dietary arachidonic acid. Lipids 33: 437-440.
8. de Gomez, I. N. T. and Brenner, R. R. (1975) Oxidative desaturation of alpha-linolenic, linoleic and stearic acids by human liver microsomes. Lipids 10: 315-317.
9. 22 fatty acids in isolated liver cells. Biochim. Biophys. Acta 796: 205-217.
10. Higashi, Y., Kanekura, T. & Kanzaki, T. (2000) Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression. Int. J. Cancer 86: 667-671.
11. Kondo, M., Yamamoto, H., Nagano, H., Okami, J., Ito, Y., Shimizu, J., Eguchi, H., Miyamoto, A., Dono, K., Umeshita, K., Matsuura, N., Wakasa, K., Nakamori, S., Sakon, M. & Monden, M. (1999) Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin. Cancer Res. 5: 4005-4012.
12. Kulkarni, S., Rader, J. S., Zhang, F., Liapis, H., Koki, A. T., Masferrer, J. L., Subbaramaiah, K. & Dannenberg, A. J. (2001) Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin. Cancer Res. 7: 429-434.
13. Okami, J., Yamamoto, H., Fujiwara, Y., Tsujie, M., Kondo, M., Noura, S., Oshima, S., Nagano, H., Dono, K., Umeshita, K., Ishikawa, O., Sakon, M., Matsuura, N., Nakamori, S. & Monden, M. (1999) Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin. Cancer Res. 5: 2018-2024.
14. Shamma, A., Yamamoto, H., Doki, Y., Okami, J., Kondo, M., Fujiwara, Y., Yano, M., Inoue, M., Matsuura, N., Shiozaki, H. & Monden, M. (2000) Upregulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin. Cancer Res. 6: 1229-1238.
15. Shirahama, T. (2000) Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin. Cancer Res. 6: 2424-2430.
16. Kargman, S. L., O'Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A. & Jothy, S. (1995) Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res. 55: 2556-2559.
17. Parrett, M. L., Harris, R. L., Joarder, F. S., Ross, M. S., Clausen, K. P. & Robertson, F. M. (1997) Cyclooxygenase-2 gene expression in human breast cancer. Int. J. Oncol. 10: 503-508.
18. Hwang, D., Scollard, D., Byrne, J. & Levine, E. (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Natl. Cancer Inst. 90: 455-460.
19. Michalowski, J. (2002) COX-2 inhibitors: cancer trials test new uses for pain drug. J. Natl. Cancer Inst. 94: 248-249.
20. Marx, J. (2001) Cancer research. Anti-inflammatories inhibit cancer growth - But how? Science (Washington, DC) 291: 581-582.
21. Vainio, H. (2001) Is COX-2 inhibition a panacea for cancer prevention? Int. J. Cancer 94: 613-614.
22. Thun, M. J., Henley, S. J. & Patrono, C. (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94: 252-266.
23. Obata, T., Nagakura, T., Masaki, T., Maekawa, K. & Yamashita, K. (1999) Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin. Exp. Allergy 29: 1129-1135.
24. Hamid, R., Singh, J., Reddy, B. S. & Cohen, L. A. (1999) Inhibition by dietary menhaden oil of cyclooxygenase-1 and-2 in N-nitrosomethylurea-induced rat mammary tumors. Int. J. Oncol. 14: 523-528.
25. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. & Reddy, B. S. (1995) Chemoprevention of colon carcinogenesis by Sulindac, a nonsteroidal antiinflammatory agent. Cancer Res. 55: 1464-1472.
26. Reddy, B. S., Nayini, J., Tokumo, K., Rigotty, J., Zang, E. & Kelloff, G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L,-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50: 2562-2568.
27. Needleman, P., Raz, A., Minkes, M. S., Ferrendelli, J. A. & Specher, H. (1979) Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties. Proc. Natl. Acad. Sci. U.S.A. 76: 944-948.
28. Schwartz, S. A., Hernandez, A. & Evers, B. M. (1999) The role of NFκB/IκB proteins in cancer; implications for novel treatment strategies. Surg. Oncol. 8: 143-153.
29. Barber, M. D., Fearon, K. C. H., Tisdale, M. J., McMillan, D. C. & Ross, J. A. (2001) Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr. Cancer 40: 118-124.
30. Babcock, T., Helton, W. S. & Espat, N. J. (2000) Eicosapentaenoic acid (EPA): An antiinflammatory ω-3 fat with potential clinical applications. Nutrition 16: 1116-1118.
31. Craven, P. A. and DeRubertis, F. R. (1988) Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation by unsaturated fatty acids. Gastroenterology 95: 676-685.
32. Rose, D. P. and Connolly, J. M. (1999) Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Therap. 83: 217-244.
33. McCarty, M. F. (1996) Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med. Hypotheses 46: 107-115.
34. Collett, E. D., Davidson, L. A., Fan, Y.-Y., Lupton, J. R. & Chapkin, R. S. (2001) n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am. J. Physiol. Cell Physiol. 280: C1066-C1075.
35. Liu, G., Bibus, D. M., Bode, A. M., Ma, W.-Y., Holman, R. T. & Dong, Z. (2001) Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc. Natl. Acad. Sci. U.S.A. 98: 7510-7515.
36. Rose, D. P. and Connolly, J. M. (1993) Effects of dietary omega-3 fatty acids on human breast cancer growth and metastasis in nude mice. J. Natl. Cancer Inst. 85: 1743-1747.
37. Rose, D. P., Connolly, J. M., Rayburn, J. & Coleman, M. (1995) Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J. Natl. Cancer Inst. 87: 587-592.
38. Buckman, D. K., Hubbard, N. E. & Erickson, K. J. (1991) Eicosanoids and linoleate-enhanced growth of mouse mammary tumor cells. Prostaglandins Leuko. Essent. Fatty Acids 44: 177-184.
39. Abou-El-Ela, S. H., Prasse, K. W., Carroll, R., Wade, A. E., Dharwadkar, S. & Bunce, O. R. (1988) Eicosanoid synthesis in 7,12-dimethyl-benz(a)anthracene-induced mammary carcinomas in Sprague Dawley rats fed primrose oil, menhaden oil or corn oil. Lipids 23: 948-954.
40. Tsujii, M. and Dubois, R. N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpression prostaglandin endoperoxide synthase 2. Cell 83: 493-501.
41. Narayanan, B. A., Narayanan, N. K. & Reddy, B. S. (2001) Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Internatl. J. Oncol. 19: 1255-1262.
42. Chiu, L. C. M. and Wan, J. M. F. (1999) Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett. 145: 17-27.
43. Wang, M., Liu, Y. E., Ni, J., Aygun, B., Goldberg, I. D. & Shi, Y. E. (2000) Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an ω-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res. 60: 6482-6487.
44. 2 and angiogenesis. Proc. Soc. Exp. Biol. Med. 172: 214-218.
45. Connolly, J. M. and Rose, D. P. (1998) Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. Cancer Lett. 132: 107-112.
46. Weihua, Z., Mäkelä, S., Andersson, L. C., Salmi, S., Sail, S., Webster, J. I., Jensen, E. V., Nilsson, S., Warner, M. & Gustafsson, J.-Ä. (2001) A role for estrogen receptor β in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 98: 6330-6335.
47. Foley, E. F., Jazaeri, A. A., Shupnik, M. A., Jazaeri, O. & Rice, L.W. (2000) Selective loss of estrogen receptor beta in malignant human colon. Cancer Res. 60: 245-248.
48. 2 stimulates aromatase expression in endometriosis-derived stromal cells. J. Clin. Endocrinol. Metab. 82: 600-602.
49. Telang, N. T., Basu, A., Kurihara, H., Osborne, M. P. & Modak, M. J. (1988) Modulation in the expression of murine mammary tumor virus ras proto-oncogene, and of alveolar hyperplasia by fatty acids in mouse mammary explant cultures. Anticancer Res. 8: 971-976.
50. Osborne, M. P., Karmali, R. A., Herschcopf, R. J., Bradlow, H. L., Kourides, I. A., Williams, W. R., Rosen, P. P. & Fishman, J. (1988) Omega-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest. 6: 629-632.
51. Deschner, E. E., Lytle, J. S., Wong, G., Ruperto, J. F. & Newmark, H. L. (1990) The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumor incidence. Cancer 66: 2350-2356.
52. Fernandes, G., Friedrichs, W., Schultz, J. & Venkatraman, J. (1989) Modulation of MCF-7 tumor cell growth in nude mice by omega-3 fatty acid diet. Breast Cancer Res. Treat. 14: 179.
53. Karmali, R. A., Marsh, J. & Fuchs, C. (1984) Effect of omega-3 fatty acids on growth of a rat mammary tumor. J. Natl. Cancer Inst. 73:457-461.
54. Karmali, R. A., Reichel, P., Cohen, L. A., Terano, T., Hirai, A., Tamura, Y. & Yoshida, S. (1987) The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res. 7: 1173-1179.
55. Reddy, B. S. and Sugie, S. (1988) Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48: 6642-6647.
56. Boudreau, M. D., Sohn, K. H., Rhee, S. H., Lee, S. W., Hunt, J. D. & Hwang, D. H. (2001) Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: Mediation through cyclooxygenase-independent pathways. Cancer Res. 61: 1386-1391.
57. Borgeson, C. E., Pardini, L., Pardini, R. S. & Reitz R. C. (1989) Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes. Lipids 24: 290-295.
58. Gonzalez, M. J., Schemmel, R. A., Gray, J. I., Dugan, L. J., Sheffield, L. G. & Welsch, C. W. (1991) Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: Relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis 12: 1231-1235.
59. 3 on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet. Br. J. Cancer 76: 347-354.
60. Holroyde, C. P., Skutches, C. L. & Reichard, F. A. (1988) Effect of dietary enrichment of N-3 polyunsaturated fatty acids (PUFA) in metastatic breast cancer. Proc. Soc. Clin. Oncol. 7: 42.
61. Lindner, M. A. (1991) A fish oil diet inhibits colon cancer in mice. Nutr. Cancer 15: 1-11.
62. Shao, Y., Pardini, L. & Pardini, R. S. (1995) Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 30: 1035-1045.
63. Shao, Y., Hull, J., Pardini, L. & Pardini, R. S. (1997) Dietary menhaden oil improves the therapeutic index of cyclophosphamide and 5-fluorouracil towards MX-1 human mammary carcinoma in athymic mice. Proc. Am. Assoc. Cancer Res. 38: 110.
64. Calviello, G., Paola, P., Maggiano, N., Franceschelli, P., Di Nicuolo, F., Marcocci, M. E. & Bartoli, G. M. (1999) Effects of eicosapentaenoic and docosahexaenoic acids dietary supplementation on cell proliferation and apoptosis in rat colonic mucosa. Lipids 34: S111.
65. Rose, D. P., Connolly, J. M. & Liu, X.-H. (1997) Fatty acid regulation of breast cancer cell growth and invasion. In: Dietary Fat and Cancer (American Institute for Cancer Research, ed.), pp. 47-56. Plenum Press, New York.
66. Ziegler, R. G., Hoover, R. L., Pike, M. C., Hildesheim, A., Nomura, A. M. Y., West, D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-Ross, P. I., Rosenthal, J. F. & Hyer, M. B. (1993) Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst. 85: 1819-1827.
67. Wynder, E. L., Fujita, Y., Harris, R. E., Hirayama, T. & Hirayama, T. (1991) Comparative epidemiology of cancer between the United States and Japan: A second look. Cancer 67: 746-763.
68. Abou-El-Ela, S. H., Prasse, K. W., Farrell, R. L., Carroll, R. W., Wade, A. E. & Bunce, O. R. (1989) Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res. 49: 1434-1440.
69. Simonsen, N., van't Veer, P., Strain, J. J., Martin-Moreno, J. M., Huttunen, J. K., Navajas, J. F., Martin, B. C., Thamm, M., Kardinaal, A. F., Kok, F. J. & Kohlmeier, L. (1998) Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Am. J. Epidemiol. 147: 342-352.
70. Maillard, V., Bougnoux, P., Ferrari, P., Jourdan, M. L., Pinault, M., Lavillonnière, F., Body, G., Floch, O. L. & Chajès, V. (2002) n-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int. J. Cancer 98: 78-83.
71. Simopoulos, A. P. (1991) Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54: 438-463.
72. POS Pilot Plant Corporation, Saskatoon, Saskatchewan, Canada, June. (1994) Available from Canola Council of Canada, Publications, Fat Charts, at http://www.canola-council.org/. Accessed July 18, 2002.